FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36092711000001103: Daclizumab 25mg/5ml solution for infusion vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111127601000001116 Daclizumab 25mg/5ml solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111127701000001114 Daclizumab 25mg/5ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daclizumab 25mg/5ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Is a Daclizumab true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Is a Product containing daclizumab false Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has active ingredient Daclizumab false Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has specific active ingredient Daclizumab true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Daclizumab 25mg/5ml solution for injection vials 3 vial Has VMP True Daclizumab 25mg/5ml solution for infusion vials Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Is a True Daclizumab 25mg/5ml solution for infusion vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start